The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis

    NEXT STORY
    GigaGen to Present at the Inaugural LifeSci Partners Private Company Virtual Summer Symposium
    PREV STORY
    Smile Direct Club Now Serving Orthodontia’s Largest and Fastest-Growing Segment: Teens
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    FedDev Ontario Supports New Microbix Facility in Mississauga

    author_avatar
    NASDAQ Market News

    IoT Technologies with Advanced Artificial Intelligence to Redefine COVID-19 Care Management

    author_avatar
    NASDAQ Market News

    Madrigal Pharmaceuticals Reports 2018 Fourth Quarter and Full Year Financial Results and Highlights

    author_avatar
    NASDAQ Market News